This statistic shows the change in revenue of Sanofi's top pharmaceuticals in 2024 compared to the previous year. Dupixent, a rare blood disorder drug, showed the highest growth rate among all of Sanofi's best-selling pharmaceutical drugs, at over 23 percent.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Sanofi, & Company filings. (February 17, 2025). Change in revenue of Sanofi's leading pharmaceuticals in 2024 compared to previous year [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 30, 2026, from /statistics/266510/sanofi-aventis-change-in-revenue-with-top-pharmaceuticals/
Sanofi, und Company filings. "Change in revenue of Sanofi's leading pharmaceuticals in 2024 compared to previous year." Chart. February 17, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 30, 2026. /statistics/266510/sanofi-aventis-change-in-revenue-with-top-pharmaceuticals/
Sanofi, Company filings. (2025). Change in revenue of Sanofi's leading pharmaceuticals in 2024 compared to previous year. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 30, 2026. /statistics/266510/sanofi-aventis-change-in-revenue-with-top-pharmaceuticals/
Sanofi, and Company filings. "Change in Revenue of Sanofi's Leading Pharmaceuticals in 2024 Compared to Previous Year." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 17 Feb 2025, /statistics/266510/sanofi-aventis-change-in-revenue-with-top-pharmaceuticals/
Sanofi & Company filings, Change in revenue of Sanofi's leading pharmaceuticals in 2024 compared to previous year ÌÇÐÄÆƽâ°æ, /statistics/266510/sanofi-aventis-change-in-revenue-with-top-pharmaceuticals/ (last visited July 30, 2026)
Change in revenue of Sanofi's leading pharmaceuticals in 2024 compared to previous year [Graph], Sanofi, & Company filings, February 17, 2025. [Online]. Available: /statistics/266510/sanofi-aventis-change-in-revenue-with-top-pharmaceuticals/
